In partnership with
Good morning, {{first_name | startup founders}}.
Simile just proved that AI models pretending to be your customers are worth real money. The synthetic-user startup closed a $200 million Series B at a $2 billion valuation — five months after its $100 million Series A — with Fortune 100 companies like CVS Health already running simulations instead of focus groups.
If a research tool that never talks to a real human can command a $2 billion price tag, how much longer before synthetic panels replace traditional market research entirely? Elsewhere, chipmakers and security teams are placing similar bets on AI agents that work faster than the humans they’re built to assist.
In today’s Startup News AI:
Simile hits $2B valuation five months after its Series A
ChipAgents grows its Series A to $134M for chip design
Cantina launches with $8M to automate security work
What’s new?
Simile closed a $200 million Series B at a $2 billion valuation, just five months after its $100 million Series A — a jump that shows investors betting big on AI models that simulate how real people think and act.
Two Minutes to Know What Slow Billing Is Costing You
Most SaaS finance teams know their billing process is slow.Most SaaS finance teams know their billing process is slow. Few know what it's costing them.
The Tabs Billing Lag Calculator puts a dollar figure on it in two minutes — benchmarked against top SaaS companies.
What matters?
Greenoaks led the round, with Index Ventures increasing its stake and new backer Definition joining alongside returning investors Bain Capital Ventures, Hanabi, A*, Factory and CVS Health Ventures.
Founder Joon Sung Park, a Stanford PhD who built the “Smallville” simulated-agent research project, has turned academic work on believable AI behavior into a product for marketing and product research.
Revenue is up 5x since Simile’s public launch, with the company running tens of millions of simulations for Fortune 100 customers including CVS Health.
Why it matters?
Investors are no longer treating synthetic-user research as a novelty — they’re pricing it like enterprise software. A five-month jump from a $100M Series A to a $2B valuation signals that AI models predicting human behavior are becoming a serious budget line for corporate research teams, not just a research curiosity.
What’s new?
ChipAgents expanded its Series A by $60 million to $134 million total, as semiconductor giants pay for AI agents that handle chip design, verification and debugging work that used to take engineering teams months.
What matters?
New investor B Capital joined existing backers Bessemer Venture Partners, Micron, MediaTek and Ericsson in the A2 round, with strategic chipmakers essentially funding their own AI tooling supplier.
Annual recurring revenue is up 6x in the first half of 2026, with the platform now deployed across more than 120 semiconductor companies.
ChipAgents claims its autonomous agents can cut chip design cycles by more than 50%, compressing months of manual verification work into days.
Why it matters?
When Micron and MediaTek both invest in and buy from the same 2-year-old startup, that’s a strong signal the semiconductor industry sees agentic AI as core infrastructure, not an experiment. Expect more chipmakers to bet on AI-native design tools rather than build them in-house as talent for this work stays scarce.
SPONSORED BY MINTLIFY
AI Agents Are Reading Your Docs. Are You Ready?
Last month, 48% of visitors to documentation sites across Mintlify were AI agents, not humans.
Claude Code, Cursor, and other coding agents are becoming the actual customers reading your docs. And they read everything.
This changes what good documentation means. Humans skim and forgive gaps. Agents methodically check every endpoint, read every guide, and compare you against alternatives with zero fatigue.
Your docs aren't just helping users anymore. They're your product's first interview with the machines deciding whether to recommend you.
That means: clear schema markup so agents can parse your content, real benchmarks instead of marketing fluff, open endpoints agents can actually test, and honest comparisons that emphasize strengths without hype.
Mintlify powers documentation for over 20,000 companies, reaching 100M+ people every year. We just raised a $45M Series B led by @a16z and @SalesforceVC to build the knowledge layer for the agent era.
What’s new?
Cantina launched from stealth with an $8 million round led by Framework Ventures, bringing its total funding to $16.5 million, to build a community-powered agentic security platform that finds, prioritizes and fixes vulnerabilities without waiting on a human analyst.
What matters?
The platform maps every identity and asset in a company’s environment — from Okta logins to AWS roles to databases holding customer data — then layers in business context to prioritize real risk over noise.
Cantina already serves Fortune 500 and mid-market customers across healthcare and fintech, sectors where regulators punish slow vulnerability remediation the hardest.
The startup holds trusted access with OpenAI and is a participant in Anthropic’s Cyber Verification Program, putting it inside two of the biggest AI labs’ security testing loops.
Why it matters?
As attackers increasingly use AI agents to find and exploit vulnerabilities faster than human teams can patch them, security vendors that can’t match that speed will lose enterprise deals. Cantina’s early access to OpenAI’s and Anthropic’s own verification programs gives it a credibility edge that’s hard for competitors to replicate quickly.
The Shortlist
Enigma raised a $71 million seed round co-led by Index Ventures and Ribbit Capital to build AI foundation models that make any robot easier to control, backed by angel investors from OpenAI, Anthropic and DeepMind.
Oak emerged from stealth with $60 million in seed funding led by Accel, Greylock and CRV to build an AI-native identity platform that revokes unnecessary access in real time instead of relying on manual reviews.
OneMedNet secured an $11.5 million-plus agreement to supply de-identified medical imaging and clinical data from its 90 million-patient network for training a foundational AI model.